Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026)
Turn Therapeutics' (TTRX) quarterly Cash from Operations came in at 1600000.0 in Q1 2026, down 436.81% year-on-year from 475047.71 in Q1 2025, and down 32.23% quarter-over-quarter from 1210000.0 in Q4 2025.
Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026) Analysis & Trends
Turn Therapeutics' Cash from Operations history runs 3 years deep, the most recent figure standing at 1600000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 436.81% year-over-year to 1600000.0 in Q1 2026; TTM through Mar 2026 was 3538603.0, a N/A change from a year earlier, with the FY2025 full-year figure at 2600000.0, down 90.99% from the prior year.
- Cash from Operations fell to 1600000.0 in Q1 2026 per TTRX's latest filing, from 1210000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 298058.0 in Q1 2025 and bottomed at 1600000.0 in Q1 2026.
- The 3-year median for Cash from Operations is 820272.5 (2024), against an average of 884650.75.
- Across the five-year window, Cash from Operations slumped 181.04% in 2025 and tumbled 436.81% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 430545.0 in 2024, then plunged by 181.04% to 1210000.0 in 2025, then slumped by 32.23% to 1600000.0 in 2026.
- Per Business Quant, the three latest TTRX Cash from Operations figures stand at 1600000.0 (Q1 2026), 1210000.0 (Q4 2025), and 298058.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Turn Therapeutics | 282.39 Mn | 282.39 Mn | - | -1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.60 Mn |
| Mar 31, 2026 | -1.60 Mn |
| Dec 31, 2025 | -1.21 Mn |
| Dec 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -298,058.00 |
| Mar 31, 2025 | -298,058.00 |
| Dec 31, 2024 | -430,545.00 |
| Dec 31, 2024 | -430,545.00 |